Open Abdomen and Delayed Anastomosis After Anastomotic Dehiscences to Avoid Stomas
STOP-STOMA
Clinical Trial Phase III to Evaluate the Effectiveness of the Open Abdomen as a Bridge Therapy to Perform Transit Reconstruction in Patients With Anastomosis Dehiscence.
1 other identifier
interventional
80
1 country
1
Brief Summary
Phase III clinical trial to evaluate the efficacy of the open abdomen as bridging therapy to perform transit reconstruction in patients with anastomotic dehiscence. It is a randomized controlled single-center study that will be carried out at the Virgen del Rocío University Hospital in Seville.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2021
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJune 15, 2022
June 1, 2022
1.8 years
November 19, 2021
June 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy-Stoma after discharge
To assess the efficacy of the open abdomen surgical strategy with delayed anastomosis in patients requiring reoperation for anastomotic dehiscence. Number of stoma after discharge
up to 57 months
Secondary Outcomes (5)
Mortality
up to 57 months
Intensive Care Unit stay
up to 57 months
Complications of open abdomen
up to 57 months
Early complications
up to 57 months
Late complications
up to 57 months
Study Arms (2)
Intervention group
EXPERIMENTALThe patients included in the experimental group will be operated on, performing the resection of the intestinal segment affected by the dehiscence, the sectioned intestinal ends will be left without anastomosis, and open abdomen therapy will be established. After surgery, the patient will be cared for in the intensive care unit where intensive resuscitation will be carried out in order to improve the general conditions of the patient. After 48 ± 24 hours, a second surgical procedure will be performed where local conditions will be evaluated and the possibility of performing a delayed anastomosis will be evaluated.
Control group
ACTIVE COMPARATORThe patients included in the control group will be operated on with a resection of the affected intestinal segment and a stoma with or without associated mucosal fistula will be performed at the same surgical time. After the procedure, the patient will be cared for in the intensive care unit in order to improve the general conditions of the patient.
Interventions
Eligibility Criteria
You may qualify if:
- Patients with intestinal, ileocolic, colo-colic and colorectal anastomosis dehiscence.
You may not qualify if:
- Dehiscence of colorectal anastomosis in the middle or lower rectum.
- Dehiscence of esophagus-gastric or gastro-intestinal anastomosis.
- Dehiscence of a colorectal anastomosis in which it is impossible to close the rectal stump.
- Failure to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Virgen del Rocío, Sevilla
Seville, 41013, Spain
Study Officials
- PRINCIPAL INVESTIGATOR
Virginia Durán Muñoz-Cruzado, PhD
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Central Study Contacts
Servicio de Cirugía General y del Aparato Digestivo Hospital Universitario Virgen del Rocío
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2021
First Posted
February 10, 2022
Study Start
August 1, 2022
Primary Completion
May 1, 2024
Study Completion
September 1, 2024
Last Updated
June 15, 2022
Record last verified: 2022-06